- Home
- KRMD vs CGTX Comparison
KRMD vs CGTX Comparison
Compare KRMD & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- CGTX
- Stock Information
- Founded
- KRMD 1980
- CGTX 2007
- Country
- KRMD United States
- CGTX United States
- Employees
- KRMD N/A
- CGTX N/A
- Industry
- KRMD Medical/Dental Instruments
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- CGTX Health Care
- Exchange
- KRMD Nasdaq
- CGTX Nasdaq
- Market Cap
- KRMD 192.3M
- CGTX 158.8M
- IPO Year
- KRMD N/A
- CGTX 2021
- Fundamental
- Price
- KRMD $3.86
- CGTX $1.57
- Analyst Decision
- KRMD Strong Buy
- CGTX Strong Buy
- Analyst Count
- KRMD 4
- CGTX 3
- Target Price
- KRMD $4.63
- CGTX $2.83
- AVG Volume (30 Days)
- KRMD 68.6K
- CGTX 1.7M
- Earning Date
- KRMD 11-12-2025
- CGTX 11-07-2025
- Dividend Yield
- KRMD N/A
- CGTX N/A
- EPS Growth
- KRMD N/A
- CGTX N/A
- EPS
- KRMD N/A
- CGTX N/A
- Revenue
- KRMD $36,848,451.00
- CGTX N/A
- Revenue This Year
- KRMD $21.08
- CGTX N/A
- Revenue Next Year
- KRMD $16.37
- CGTX N/A
- P/E Ratio
- KRMD N/A
- CGTX N/A
- Revenue Growth
- KRMD 19.57
- CGTX N/A
- 52 Week Low
- KRMD $1.86
- CGTX $0.22
- 52 Week High
- KRMD $5.05
- CGTX $3.83
- Technical
- Relative Strength Index (RSI)
- KRMD 41.40
- CGTX 45.37
- Support Level
- KRMD $3.80
- CGTX $1.53
- Resistance Level
- KRMD $3.99
- CGTX $1.83
- Average True Range (ATR)
- KRMD 0.15
- CGTX 0.14
- MACD
- KRMD -0.04
- CGTX -0.02
- Stochastic Oscillator
- KRMD 16.51
- CGTX 8.51
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.